Skip to main content
MAXCYTE, INC. logo

MAXCYTE, INC. — Investor Relations & Filings

Ticker · MXCT ISIN · US57777K1060 LEI · 54930053YHXULRFCU991 US Professional, scientific and technical activities
Open in API
Filings indexed 767 across all filing types
Latest filing 2024-06-10 Director's Dealing
Country US United States of America
Listing US MXCT

About MAXCYTE, INC.

https://www.maxcyte.com/

MaxCyte, Inc. is a cell-engineering company that provides enabling platform technologies to advance the discovery, development, and commercialization of cell-based therapeutics. Its core offering is the ExPERT™ platform, which utilizes proprietary Flow Electroporation® technology for efficient, scalable, and non-viral transfection of complex cells. This technology supports a wide range of applications, including cell therapy, gene editing, antibody and protein production, and vaccine development. Additionally, MaxCyte offers SeQure™ genotoxicity assessment services to evaluate the safety of gene-edited products by detecting on- and off-target effects. The company employs a partnership-driven licensing model to support clients from early-stage research through to clinical and commercial manufacturing.

Recent filings

Filing Released Lang Actions
Director's Dealing 2024
Director's Dealing
2024-06-10 English
Total Voting Rights
Regulatory Filings Classification · 1% confidence The document is an RNS (Regulatory News Service) announcement from MaxCyte, Inc. regarding 'Total Voting Rights and Block Listing Return'. It details the issuance of common stock due to share option exercises and provides a block listing return table as required by AIM Rules. While it mentions share issuance, it is primarily a regulatory disclosure of voting rights and block listing status, which falls under the 'Regulatory Filings' (RNS) category as it is a standard regulatory notification provided via the London Stock Exchange's RNS platform.
2024-06-03 English
Participation in Upcoming Investor Conference
Regulatory Filings Classification · 1% confidence The document is a short announcement (under 5,000 characters) issued via the Regulatory News Service (RNS) regarding MaxCyte, Inc.'s participation in an upcoming investor conference (William Blair 44th Annual Growth Stock Conference). It does not contain the presentation materials themselves, but rather announces the event and provides a link to the company's investor relations website. Per the 'Menu vs Meal' rule, this is classified as a Regulatory Filing (RNS) as it is a general corporate announcement that does not fit into more specific categories like Earnings Release or Investor Presentation.
2024-05-29 English
Signing of Strategic Platform License
Regulatory Filings Classification · 1% confidence The document is a press release issued via the Regulatory News Service (RNS) announcing a strategic platform license agreement between MaxCyte, Inc. and Legend Biotech. It details the nature of the partnership, the technology involved, and the financial implications (licensing fees and royalties). As it is a corporate announcement regarding a business development/partnership rather than a formal financial report, audit, or proxy statement, it falls under the category of general regulatory announcements.
2024-05-22 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is a 'TR-1: Notification of major holdings' form, which is the standard regulatory filing used in the UK to disclose significant changes in share ownership (crossing thresholds). It identifies BlackRock, Inc. as the entity subject to the notification obligation regarding its holdings in MaxCyte, Inc. This fits the definition of a Major Shareholding Notification (MRQ).
2024-05-20 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is a 'TR-1: Notification of major holdings' form, which is the standard regulatory filing used in the UK to disclose when a shareholder's interest in a company crosses specific voting rights thresholds. This falls under the 'Major Shareholding Notification' category.
2024-05-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.